Pure Global
NCT06411951

Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program

Integrated Care After Repeated Psychiatric Hospital Stays (INTUK) - Evaluation of an Interdisciplinary Treatment Program
Michael Rufer·ClinicalTrials.gov·otherEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization
Drug/Device/Intervention
Participation in the INTUK care offer at Klinik Zugersee
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Michael Rufer
Funder
Triaplus AG Klinik Zugersee - Zentrum für Psychiatrie und Psychotherapie
Location
Oberwil, Switzerland
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Dec 31, 2027
Enrollment
90 participants
Primary outcome

Admission rate

Summary

The study aims to evaluate the treatment effects as well as inhibiting and promoting factors
 in the implementation of the new INTUK care offer in a sample of heavy users, i.e.
 psychiatric patients with 4 or more prior inpatient admissions at Klinik Zugersee, by means
 of a longitudinal, prospective-retrospective study. For this purpose, medical records will be
 analysed and participants will be asked to fill out questionnaires addressing different
 aspects of mental health, quality of life and patient satisfaction. In addition,
 semi-structured interviews will be conducted with a subset of patients as well as staff
 members of the INTUK care offer.

ICD-10 classifications
Other mental disorders due to brain damage and dysfunction and to physical diseaseOther specified mental disorders due to brain damage and dysfunction and to physical diseaseProblems related to medical facilities and other health careOther problems related to medical facilities and other health careGeneral psychiatric examination, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06411951
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06411951 through Pure Global AI's free database. This phase not specified trial is sponsored by Michael Rufer and is currently Enrolling by invitation. The study focuses on High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.